Skip to main content
Year archive

Lupin Ltd — 2021 filings

All 283 regulatory filings released by Lupin Ltd (LUPIN) in 2021, sourced directly from the official regulator.

283 Filings
2021 Period
2021 filings (283)
Filing Released Lang
Loss of Share Certificates
Regulatory Filings
2021-12-31 English
Intimation regarding issuance of duplicate share certificate.
Regulatory Filings
2021-12-31 English
Lupin Receives Approval from U.S. FDA for Sevelamer Carbonate for Oral Suspension.
Regulatory Filings
2021-12-25 English
Press Release
Regulatory Filings
2021-12-25 English
Loss of Share Certificates
Regulatory Filings
2021-12-24 English
Intimation regarding loss of share certificate by the share holder.
Regulatory Filings
2021-12-24 English
Press Release
Regulatory Filings
2021-12-24 English
Lupin Receives Tentative Approval from U.S. FDA for Azilsartan Medoxomil Tablets.
Regulatory Filings
2021-12-24 English
Intimation regarding loss of share certificate by the share holders.
Regulatory Filings
2021-12-23 English
Loss of Share Certificates
Regulatory Filings
2021-12-23 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-12-22 English
Revised disclosure pursuant to grant of options under Lupin Subsidiary Companies Employees Stock Option Plan 2014.
Regulatory Filings
2021-12-22 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-12-17 English
Disclosure pursuant to allotment of 53374 shares under ESOP.
Regulatory Filings
2021-12-17 English
Press Release (Revised)
Regulatory Filings
2021-12-14 English
Lupin's Goa Manufacturing Plant Receives EIR from US FDA.
Regulatory Filings
2021-12-14 English
Lupin's Goa Manufacturing Plant Receives EIR from US FDA.
Regulatory Filings
2021-12-14 English
Press Release
Regulatory Filings
2021-12-14 English
Loss of Share Certificates
Regulatory Filings
2021-12-10 English
Intimation regarding issuance of duplicate share certificate to the shareholder in lieu of lost share certificate.
Regulatory Filings
2021-12-10 English
Intimation regarding issuance of duplicate share certificate to the shareholder in lieu of lost share certificate.
Regulatory Filings
2021-12-10 English
Press Release
Regulatory Filings
2021-12-10 English
Lupin Announces the launch of its Diagnostics Business.
Regulatory Filings
2021-12-10 English
Press Release
Regulatory Filings
2021-12-03 English
Lupin and Biomm Enter into a Distribution and Marketing Agreement for Pegfilgrastim in Brazil.
Regulatory Filings
2021-12-03 English
Lupin Partners with TTP plc UK for Soft-mist Inhalation Technology Platform.
Regulatory Filings
2021-12-02 English
Press Release
Regulatory Filings
2021-12-02 English
Disclosure pursuant to grant of 551647 options under Lupin ESOP.
Regulatory Filings
2021-12-01 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-12-01 English
Press Release
Regulatory Filings
2021-11-30 English
Lupin launches Sciflix a mobile-friendly learning platform for post graduate students specializing in pulmonology.
Regulatory Filings
2021-11-30 English
Disclosure pursuant to allotment of 92688 shares under ESOP.
Regulatory Filings
2021-11-25 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-11-25 English
Loss of Share Certificates
Regulatory Filings
2021-11-25 English
Intimation of loss of share certificates by the shareholders.
Regulatory Filings
2021-11-25 English
Loss of Share Certificates
Regulatory Filings
2021-11-11 English
Intimation regarding issuance of duplicate share certificate.
Regulatory Filings
2021-11-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-11-10 English
Q2 FY2022 Earnings Conference Call
Regulatory Filings
2021-11-10 English
Lupin Raises Awareness about Mental Health by Partnering with Singer Shaan to Relaunch the Iconic Song 'Tanha Dil Tanha Safar'
Regulatory Filings
2021-11-10 English
Press Release
Regulatory Filings
2021-11-10 English
News Verification
Regulatory Filings
2021-11-09 English
Credit Rating
Regulatory Filings
2021-11-09 English
Credit rating on enhanced bank facilities.
Regulatory Filings
2021-11-09 English
Reply to your email dated November 8, 2021, captioned 'Verification - November 08, 2021 - LUPIN LTD (500257).
Regulatory Filings
2021-11-09 English
LupinLife's Be One wins the best packaging design, graphics and brand value add award at the India Packaging Awards 2021.
Regulatory Filings
2021-11-08 English
Press Release
Regulatory Filings
2021-11-08 English
Lupin's Namuscla® (mexiletine) is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders.
Regulatory Filings
2021-11-04 English
Press Release
Regulatory Filings
2021-11-04 English
Press Release
Regulatory Filings
2021-11-03 English
Lupin Launches Authorized Generic Version of Antara® in the United States
Regulatory Filings
2021-11-03 English
News Verification
Regulatory Filings
2021-11-02 English
Reply to your letter no. L/SURV/ONL/RV/NK/(2021-2022)/34 dated October 29, 2021.
Regulatory Filings
2021-10-29 English
Investor Presentation Q2 FY2022.
Investor Presentation
2021-10-28 English
Investor Presentation
Investor Presentation
2021-10-28 English
Press Release
Regulatory Filings
2021-10-27 English
Press Release covering the unaudited financial results of the Company for the quarter and half-year ended September 30, 2021.
Regulatory Filings
2021-10-27 English
Financial Result Updates
Regulatory Filings
2021-10-27 English
Unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2021.
Regulatory Filings
2021-10-27 English
Press Release
Regulatory Filings
2021-10-24 English
Lupin makes a hearty entry into Guinness World Records Creates awareness on monitoring heart rate as an indicator of overall health.
Regulatory Filings
2021-10-24 English
Press Release
Regulatory Filings
2021-10-22 English
LupinLife signs Hrithik Roshan as the brand ambassador for Be One, Ayurvedic Energy Supplement.
Regulatory Filings
2021-10-22 English
Loss of Share Certificates
Regulatory Filings
2021-10-21 English
Loss of Share Certificates
Regulatory Filings
2021-10-21 English
Intimation regarding issue of duplicate share certificates.
Regulatory Filings
2021-10-21 English
Intimation regarding loss of share certificate.
Regulatory Filings
2021-10-21 English
Disclosure in respect of allotment of 20325 equity shares upon exercising of stock options under Lupin ESOP.
Regulatory Filings
2021-10-21 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-10-21 English
Disclosure in respect of Grant of 1016 stock options under Lupin ESOP.
Regulatory Filings
2021-10-20 English
ESOP/ESOS/ESPS
Director's Dealing
2021-10-20 English
Press Release
Regulatory Filings
2021-10-14 English
Voluntary nationwide recalling of all batches of lrbesartan Tablets and lrbesartan and Hydrochlorothiazide Tablets in the US.
Regulatory Filings
2021-10-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-10-14 English
Earnings Call for Quarter - II. FY 2022 is scheduled on Thursday, October 28, 2021 at 16:30 hrs (IST).
Regulatory Filings
2021-10-14 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings
2021-10-14 English
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2021 ,inter alia, to consider and approve unaudited financial results for the ....
Regulatory Filings
2021-10-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2021-10-11 English
Loss of Share Certificates
Regulatory Filings
2021-10-11 English
Intimation regarding loss of share certificate by the sharehholder.
Regulatory Filings
2021-10-11 English
Certificate for the quarter ended at September 30, 2021.
Regulatory Filings
2021-10-07 English
Lupin Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets.
Regulatory Filings
2021-10-06 English
Press Release
Regulatory Filings
2021-10-06 English
Loss of Share Certificates
Regulatory Filings
2021-10-05 English
Intimation regarding loss of share certificate.
Regulatory Filings
2021-10-05 English
Press Release
Regulatory Filings
2021-09-28 English
Lupin Launches Droxidopa Capsules in the United States.
Regulatory Filings
2021-09-28 English
Loss of Share Certificates
Regulatory Filings
2021-09-22 English
Details of duplicate share certificate issued.
Regulatory Filings
2021-09-22 English
Disclosure in respect of allotment of 9389 shares under Lupin ESOP.
Regulatory Filings
2021-09-21 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-09-21 English
U.S.FDA inspection of Lupin's Goa (India) facility.
Regulatory Filings
2021-09-19 English
Updates
Regulatory Filings
2021-09-19 English
Loss of Share Certificates
Regulatory Filings
2021-09-17 English
Intimation of Loss of Share Certificate by the Shareholder.
Regulatory Filings
2021-09-17 English
Updates
Legal Proceedings Report
2021-09-15 English
Settlement of litigation in Glumetza® matter.
Legal Proceedings Report
2021-09-15 English
Press Release
Regulatory Filings
2021-09-15 English
Lupin Launches Authorized Generic Version of Duexis® in the United States.
Regulatory Filings
2021-09-15 English
Intimation of Grant of 11443 stock options under ESOP.
Regulatory Filings
2021-09-06 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-09-06 English
Press Release
Capital/Financing Update
2021-09-06 English
TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB.
Capital/Financing Update
2021-09-06 English
Intimation of loss of share certificate by the shareholder.
Regulatory Filings
2021-08-30 English
Loss of Share Certificates
Regulatory Filings
2021-08-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-08-26 English
Transcript of Q1 FY2022 Earnings Conference Call.
Call Transcript
2021-08-26 English
Press Release
Regulatory Filings
2021-08-24 English
Lupin Launches Luforbec® 100/6 µg pMDI, first branded generic alternative to Fostair® 100/6 µg pMDI for treatment of Asthma & COPD, in the UK.
Regulatory Filings
2021-08-24 English
Disclosure in respect of allotment of 57696 shares under Lupin Employees Stock Option Plan.
Regulatory Filings
2021-08-19 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-08-19 English
Press Release
Regulatory Filings
2021-08-16 English
Lupin Receives Tentative U.S. FDA Approval for Brivaracetam Tablets.
Regulatory Filings
2021-08-16 English
Scrutiniser''s Report for declaration of Voting Results at the Thirty-Ninth Annual General Meeting of the Company, held on Wednesday, August 11, 2021, at 4.30 p.m. (IST) through Video Conferencing/Oth
Declaration of Voting Results & Voting Rights Announcements
2021-08-13 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2021-08-13 English
Proceedings at the Thirty-Ninth Annual General Meeting (AGM) pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2021-08-11 English
Shareholders meeting
Regulatory Filings
2021-08-11 English
Q1 FY2022 Investor Presentation.
Regulatory Filings
2021-08-11 English
Investor Presentation
Investor Presentation
2021-08-11 English
Press Release
Interim / Quarterly Report Q1 2022
2021-08-10 English
Lupin Quarter I FY2022 Results.
Regulatory Filings
2021-08-10 English
Unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2021.
Regulatory Filings
2021-08-10 English
Financial Result Updates
Regulatory Filings
2021-08-10 English
Intimation in respect of loss of share certificate.
Regulatory Filings
2021-08-09 English
Loss of Share Certificates
Regulatory Filings
2021-08-09 English
Intimation in respect of loss of share certificate by the shareholder.
Regulatory Filings
2021-08-03 English
Loss of Share Certificates
Regulatory Filings
2021-08-03 English
Earnings Call for Quarter - I, FY 2022 is scheduled on Wednesday, August 11, 2021 at 19:00 hrs (IST).
Call Transcript
2021-07-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-07-31 English
Board Meeting — Financial Results
Regulatory Filings
2021-07-30 English
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve the unaudited standalone and consolidated ....
Regulatory Filings
2021-07-30 English
Press Release
Capital/Financing Update
2021-07-30 English
Lupin Acquires Southern Cross Pharma in Australia.
Capital/Financing Update
2021-07-30 English
Record Date
AGM Information
2021-07-21 English
Date of payment of dividend
AGM Information
2021-07-20 English
Allotment of 60596 shares under Lupin ESOP.
Share Issue/Capital Change
2021-07-20 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-07-20 English
Submission of the Integrated Report of the Company for the year ended March 31, 2021 along with the Notice dated July 8, 2021, convening the Thirty-Ninth Annual General Meeting of the Company, ....
Regulatory Filings
2021-07-17 English
Shareholders meeting
Regulatory Filings
2021-07-15 English
Please find attached intimation letter in respect of Annual General Meeting of Shareholders of Lupin Limited, to be held on Aug 11, 2021.
Regulatory Filings
2021-07-15 English
Press Release
Regulatory Filings
2021-07-13 English
Lupin Launches Tavaborole Topical Solution in the United States.
Regulatory Filings
2021-07-13 English
Intimation regarding loss of share certificate.
Regulatory Filings
2021-07-05 English
Loss of Share Certificates
Regulatory Filings
2021-07-05 English
Press Release
Regulatory Filings
2021-07-01 English
Lupin Announces FDA Approval of Supplemental New Drug Application for SOLOSEC® (secnidazole) for the Treatment of Trichomoniasis.
Regulatory Filings
2021-07-01 English
Press Release
Regulatory Filings
2021-06-30 English
Lupin Receives Tentative U.S. FDA Approval for Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate (TLD) Tablets under PEPFAR.
Regulatory Filings
2021-06-30 English
Loss of Share Certificates
Regulatory Filings
2021-06-29 English
Intimation regarding loss of share certificate
Regulatory Filings
2021-06-29 English
Loss of Share Certificates
Regulatory Filings
2021-06-28 English
Intimation regarding loss of share certificate.
Regulatory Filings
2021-06-28 English
Press Release
Regulatory Filings
2021-06-25 English
Lupin Launches Emtricitabine and Tenofovir Disoproxil Fumarate Tablets in the United States.
Regulatory Filings
2021-06-25 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-06-22 English
Allotment of 131894 fully paid-up equity shares of Rs. 2/- each upon exercising of options granted to the employees under Stock option plans of the Company.
Regulatory Filings
2021-06-22 English
Press Release
Regulatory Filings
2021-06-17 English
Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets.
Regulatory Filings
2021-06-17 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Regulatory Filings
2021-06-15 English
Loss of Share Certificates
Regulatory Filings
2021-06-15 English
Intimation under Reg. 39(3) regarding loss of share certificate.
Regulatory Filings
2021-06-15 English
Press Release
Regulatory Filings
2021-06-14 English
Lupin receives UK marketing authorization for Luforbec® 100/6 µg pMDI, first branded generic alternative to Fostair® 100/6 µg pMDI for treatment of Asthma & COPD.
Regulatory Filings
2021-06-14 English
Updates
Regulatory Filings
2021-06-13 English
U.S. FDA issues Warning Letter for the Company's Somerset, New Jersey (USA) facility.
Regulatory Filings
2021-06-13 English
Press Release
Regulatory Filings
2021-06-11 English
Lupin donates Oxygen generation plants in Maharashtra, Madhya Pradesh & Gujarat to aid COVID-19 relief efforts.
Regulatory Filings
2021-06-11 English
Press Release
Regulatory Filings
2021-06-07 English
Lupin Receives U.S. FDA Approval for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets.
Regulatory Filings
2021-06-07 English
Press Release
Regulatory Filings
2021-06-07 English
Lupin Launches Digital Asthma Educator platform.
Regulatory Filings
2021-06-07 English
Press Release
Regulatory Filings
2021-06-03 English
Lupin Launches Authorized Generic Version of Brovana® in the United States.
Regulatory Filings
2021-06-03 English
Updates
Regulatory Filings
2021-06-03 English
Company's entry into the digital healthcare space with a focus to provide a digital therapeutics platform for doctors and patients in India.
Regulatory Filings
2021-06-03 English
Press Release
Regulatory Filings
2021-06-02 English
Lupin announces U.S. FDA acceptance for Pegfilgrastim Biosimilar application.
Regulatory Filings
2021-06-02 English
Press Release
Capital/Financing Update
2021-05-27 English
Lupin Announces Achievement of Key Milestones for its Clinical Stage MEK Inhibitor Compound.
Capital/Financing Update
2021-05-27 English
Related Party Transactions
Regulatory Filings
2021-05-26 English
Consolidated disclosure of Related Party Transactions and balances for the half year ended March 31, 2021.
Regulatory Filings
2021-05-26 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-05-25 English
Disclosure pursuant to Reg 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in respect of allotment of 42494 shares under ESOP.
Share Issue/Capital Change
2021-05-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript
2021-05-25 English
Lupin Limited Q4 FY2021 Earnings Conference Call Transcript.
Call Transcript
2021-05-25 English
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, in respect of Grant of 1769 stock options under Lupin ESOP.
Share Issue/Capital Change
2021-05-19 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-05-19 English
Investor Presentation
Investor Presentation
2021-05-13 English
Investor Presentation Q4 FY2021.
Investor Presentation
2021-05-13 English
Annual Secretarial Compliance Report for the year ended March 31, 2021, issued by Ms. Neena Bhatia, Practising Company Secretary (FCS - 9492 CP. NO. 2661).
Regulatory Filings
2021-05-13 English
Lupin Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2021, inter alia, has recommended dividend @ 325% i.e. Rs. 6.50 per equity share of ....
Annual Report FY 2021
2021-05-13 English
Press Release
Earnings Release FY 2021
2021-05-12 English
Lupin FY2021 Results.
Earnings Release FY 2021
2021-05-12 English
Audited Results for March 2021
Annual Report FY 2021
2021-05-12 English
Financial Result Updates
Interim / Quarterly Report FY 2021
2021-05-12 English
Change in Director(s)
Board/Management Information
2021-05-10 English
Mr. Robert Funsten (DIN: 08950420), Independent Director, retired yesterday i.e. May 9, 2021, on completion of his term as an Independent Director of the Company.
Board/Management Information
2021-05-10 English
Press Release
Regulatory Filings
2021-05-10 English
Lupin enters into Voluntary Licensing Agreement with Lilly to Expand Access for COVID-19 Treatment in India.
Regulatory Filings
2021-05-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-05-04 English
Annual Investor Communication FY 2021 - Thursday, May 13, 2021 at 17.30 hrs (IST).
Regulatory Filings
2021-05-04 English
Board Meeting — Financial Results/Dividend/Other business matters
Regulatory Filings
2021-05-03 English
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2021 ,inter alia, to consider and approve the Audited Standalone and Consolidated ....
Regulatory Filings
2021-05-03 English
Acquisition
Regulatory Filings
2021-04-30 English
Updates on Acquisition.
Regulatory Filings
2021-04-30 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Capital/Financing Update
2021-04-27 English
Disclosure in terms of Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 in respect of allotment of 48277 shares under ESOP.
Share Issue/Capital Change
2021-04-27 English
Allotment of Securities
Share Issue/Capital Change
2021-04-27 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-23 English
Incorporation of wholly owned subsidiary in the USA under the name Lupin Oncology Inc.
Regulatory Filings
2021-04-20 English
Updates
Regulatory Filings
2021-04-20 English
Certificate under Reg. 40(9) of SEBI(Listing Obligations and Disclosure Requirements), Regulations, 2015 for the half year ended at March 31, 2021.
Regulatory Filings
2021-04-16 English
Half yearly certificate under Reg 7(3) of LODR as on March 31, 2021.
Regulatory Filings
2021-04-09 English
Acquisition
M&A Activity
2021-04-01 English
Lupin Limited has informed the Exchange about Acquisition.
Capital/Financing Update
2021-04-01 English
Lupin Limited has informed the Exchange about Acquisition.
Regulatory Filings
2021-03-31 English
Acquisition
M&A Activity
2021-03-31 English
Lupin Limited has informed the Exchange about Acquisition.
Regulatory Filings
2021-03-31 English
Acquisition
Regulatory Filings
2021-03-31 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Asset Management Company Ltd
Major Shareholding Notification
2021-03-31 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Regulatory Filings
2021-03-30 English
Lupin Limited has informed the Exchange about Acquisition.
Regulatory Filings
2021-03-25 English
Acquisition
Regulatory Filings
2021-03-25 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-03-24 English
Disclosure in respect of allotment of 29520 shares under ESOP.
Regulatory Filings
2021-03-24 English
Press Release
Regulatory Filings
2021-03-24 English
LupinLife Partners with Uttarakhand Police to Promote Hand Hygiene at Kumbh Mela 2021.
Regulatory Filings
2021-03-24 English
Scrutiniser''s Report for declaration of Postal Ballot Results.
Regulatory Filings
2021-03-17 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements
2021-03-17 English
Lupin Launches Authorized Generic Version of Alinia®.
Regulatory Filings
2021-03-10 English
Press Release
Regulatory Filings
2021-03-10 English
Lupin Pharma Canada Announces Partnership with Endoceutics for the commercialization of Intrarosa®.
Regulatory Filings
2021-03-09 English
Press Release
Regulatory Filings
2021-03-09 English
Disclosure in respect of allotment of 9203 shares under ESOP.
Regulatory Filings
2021-03-04 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-03-04 English
Lupin Launches Penicillamine Tablets USP.
Regulatory Filings
2021-03-02 English
Press Release
Regulatory Filings
2021-03-02 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-02-25 English
Disclosure in respect of Grant of 7748 Employee Stock Options under ESOP.
Regulatory Filings
2021-02-25 English
ESOP/ESOS/ESPS
Regulatory Filings
2021-02-25 English
Disclosure in respect of allotment of 40587 shares under ESOP.
Regulatory Filings
2021-02-25 English
Press Release
Regulatory Filings
2021-02-19 English
Lupin Receives Approval for Droxidopa Capsules.
Regulatory Filings
2021-02-19 English
Lupin Launches Posaconazole Delayed-Release Tablets.
Regulatory Filings
2021-02-17 English
Press Release
Regulatory Filings
2021-02-17 English
Allotment of Securities
Regulatory Filings
2021-02-12 English
Disclosure in respect of allotment of 3583 shares under ESOP.
Regulatory Filings
2021-02-12 English
Shareholders meeting
Regulatory Filings
2021-02-12 English
Notice of Postal Ballot dated February 10, 2021, together with Postal Ballot Form/Instructions sent by the Company to the Members in respect of seeking their approval vide Ordinary Resolutions ....
Regulatory Filings
2021-02-12 English
Transcript of the Q3 FY2021 Earnings Conference Call held on Friday, January 29, 2021
Regulatory Filings
2021-02-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-02-10 English
Press Release
Regulatory Filings
2021-02-10 English
LupinLife Launches Be One, Ayurvedic Energy Supplement.
Regulatory Filings
2021-02-10 English
Press Release
Regulatory Filings
2021-02-09 English
Lupin Receives Approval for Tavaborole Topical Solution.
Regulatory Filings
2021-02-09 English
Press Release
Board/Management Information
2021-02-02 English
Lupin Announces Appointment of New Independent Director.
Regulatory Filings
2021-02-02 English
Appointment
Regulatory Filings
2021-01-29 English
Mr. Mark D. McDade (DIN: 09037255) was appointed as an Independent Director of the Company, effective January 28, 2021 for a period of five years. i.e. up to January 27, 2026.
Regulatory Filings
2021-01-29 English
Investor Presentation-Q3-FY 2020-21.
Regulatory Filings
2021-01-28 English
Investor Presentation
Regulatory Filings
2021-01-28 English
Lupin Quarter III FY2021 Results.
Regulatory Filings
2021-01-28 English
Press Release
Regulatory Filings
2021-01-28 English
Unaudited standalone and consolidated financial results of the Company for the quarter and nine-months ended December 31, 2020.
Regulatory Filings
2021-01-28 English
Financial Result Updates
Regulatory Filings
2021-01-28 English
Allotment of Securities
Regulatory Filings
2021-01-25 English
Disclosure in respect of allotment of 83700 shares under ESOP.
Regulatory Filings
2021-01-25 English
Press Release
Regulatory Filings
2021-01-25 English
Lupin Receives Approval for Sevelamer Carbonate Tablets.
Regulatory Filings
2021-01-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-01-18 English
Earnings Call for Quarter - Ill, FY 2021 is scheduled on Friday, January 29, 2021 at 08.00 hrs (IST).
Regulatory Filings
2021-01-18 English
Investor Presentation
Investor Presentation
2021-01-12 English
Presentation to be made at the J. P. Morgan Healthcare Conference.
Regulatory Filings
2021-01-12 English
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2021 ,inter alia, to consider and approve unaudited financial results for the ....
Regulatory Filings
2021-01-12 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings
2021-01-12 English
The Company will be participating in the J P Morgan Global Healthcare Conference to be held on Tuesday, January 12, 2021.
Regulatory Filings
2021-01-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2021-01-11 English
Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets.
Regulatory Filings
2021-01-07 English
Press Release
Regulatory Filings
2021-01-07 English
Disclosure in respect of grant of 764084 Stock Options under ESOPs.
Share Issue/Capital Change
2021-01-06 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2021-01-06 English
Press Release
Regulatory Filings
2021-01-06 English
Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP.
Regulatory Filings
2021-01-06 English